However, our results were inconsistent with the previous meta-analysis, which indicated that CXCL12 rs1801157 polymorphism increased the risk of breast cancer in allelic genetic, homozygote, heterozygote, recessive genetic and dominant genetic models [18, 27]. The gene discussed is CXCL12; the disease is breast carcinoma.